Now the Trump administration intends a five-year experiment in which the Medicaid program and Medicare drug coverage plans will have the option of covering the cost of drugs selling under the names Ozempic, Wegovy, Mounjaro and Zepbound for weight management purposes, the Washington Post reported on Friday morning, citing documents from the governments Centers for Medicare & Medicaid Services (CMS)
Lymphatic system: a vital link between metabolic syndrome and inflammation
(Survodutide, dual GLP-1/Glucagon agonist from Boehringer Ingelheim) However, with that being said 3 of the molecules here are from Eli Lilly, who has basically shown a dominance of this space that Im not sure the pharmaceutical space has ever seen
Frias JP, Hsia S, Eyde S, et al
Impact of high-fat feeding on basic helixloophelix transcription factors controlling enteroendocrine cell differentiation